Yong Cheng

Dr. Yong Cheng


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YCYong Cheng
Yong Cheng
YLYurong Liang
Yurong Liang
XTXuejuan Tan
Xuejuan Tan
LLLin Liu
Lin Liu
Bacterial infections remain a significant global health concern, necessitating a comprehensive understanding of the intricate host−pathogen interactions that play a critical role in the outcome of infectious diseases. Recent investigations have revealed that noncoding RNAs (ncRNAs) are key regulators of these complex interactions. Among them, long noncoding RNAs (lncRNAs) have gained significant attention because of their diverse regulatory roles in gene expression, cellular processes and the production of cytokines and chemokines in response to bacterial infections. The host utilizes lncRNAs as a defense mechanism to limit microbial pathogen invasion and replication. On the other hand, some host lncRNAs contribute to the establishment and maintenance of bacterial pathogen reservoirs within the host by promoting bacterial pathogen survival, replication, and dissemination. However, our understanding of host lncRNAs in the context of bacterial infections remains limited. This review focuses on the impact of host lncRNAs in shaping host−pathogen interactions, shedding light on their multifaceted functions in both host defense and bacterial survival, and paving the way for future research aimed at harnessing their regulatory potential for clinical applications.

21 December 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
SKStephen Kotei Kotey
Stephen Kotei Kotey
XTXuejuan Tan
Xuejuan Tan
AKAudrey L. Kinser
Audrey L. Kinser
LLLin Liu
Lin Liu
YCYong Cheng
Yong Cheng
Mycobacterial infections, caused by various species within the Mycobacterium genus, remain one of the main challenges to global health across the world. Understanding the complex interplay between the host and mycobacterial pathogens is essential for developing effective diagnostic and therapeutic strategies. Host long noncoding RNAs (lncRNAs) have emerged as key regulators in cellular response to bacterial infections within host cells. This review provides an overview of the intricate relationship between mycobacterial infections and host lncRNAs in the context of Mycobacterium tuberculosis and non-tuberculous mycobacterium (NTM) infections. Accumulation of evidence indicates that host lncRNAs play a critical role in regulating cellular response to mycobacterial infection within host cells, such as macrophages, the primary host cells for mycobacterial intracellular survival. The expression of specific host lncRNAs has been implicated in the pathogenesis of mycobacterial infections, providing potential targets for the development of novel host-directed therapies and biomarkers for TB diagnosis. In summary, this review aims to highlight the current state of knowledge regarding the involvement of host lncRNAs in mycobacterial infections. It also emphasizes their potential application as novel diagnostic biomarkers and therapeutic targets.

18 January 2024 in Proteomics
Verified
Journal Article
Closed access
CVCharlie A. Vermeire
Charlie A. Vermeire
XTXuejuan Tan
Xuejuan Tan
YLYurong Liang
Yurong Liang
SKStephen K. Kotey
Stephen K. Kotey
JRJanet Rogers
Janet Rogers
YCYong Cheng
Yong Cheng

30 December 2023 in GeroScience
Verified
Journal Article
Open access
PDF file
SKStephen K. Kotey
Stephen K. Kotey
XTXuejuan Tan
Xuejuan Tan
OFOwen Fleming
Owen Fleming
RKRamakrishnama Raju Kasiraju
Ramakrishnama Raju Kasiraju
ADAudrey L. Dagnell
Audrey L. Dagnell
YCYong Cheng
Yong Cheng
Aging has a significant impact on the immune system, leading to a gradual decline in immune function and changes in the body’s ability to respond to bacterial infections. Non-tuberculous mycobacteria (NTM), also known as atypical mycobacteria or environmental mycobacteria, are commonly found in soil, water, and various environmental sources. While many NTM species are considered opportunistic pathogens, some can cause significant infections, particularly in individuals with compromised immune systems, such as older individuals. When mycobacteria enter the body, macrophages are among the first immune cells to encounter them and attempt to engulf mycobacteria through a process called phagocytosis. Some NTM species, including Mycobacterium avium (M. avium) can survive and replicate within macrophages. However, little is known about the interaction between NTM and macrophages in older individuals. In this study, we investigated the response of bone marrow–derived macrophage (BMMs) isolated from young (5 months) and old (25 months) mice to M. avium serotype 4, one of the main NTM species in patients with pulmonary NTM diseases. Our results demonstrated that BMMs from old mice have an increased level of intracellular iron and are more susceptible to M. avium serotype 4 infection compared to BMMs from young mice. The whole-cell proteomic analysis indicated a dysregulated expression of iron homeostasis–associated proteins in old BMMs regardless of mycobacterial infection. Deferoxamine, an iron chelator, significantly rescued mycobacterial killing and phagolysosome maturation in BMMs from old mice. Therefore, our data for the first time indicate that an intracellular iron accumulation improves NTM survival within macrophages from old mice and suggest a potential application of iron-chelating drugs as a host-directed therapy for pulmonary NTM infection in older individuals.

16 September 2024 in Proteomics
Verified
Journal Article
Closed access
CVCharlie A. Vermeire
Charlie A. Vermeire
XTXuejuan Tan
Xuejuan Tan
ARAidaly Ramos‐Leyva
Aidaly Ramos‐Leyva
AWAva Wood
Ava Wood
SKStephen K. Kotey
Stephen K. Kotey
YCYong Cheng
Yong Cheng

26 October 2023 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
CGCarlyn Monèt Guthrie
Carlyn Monèt Guthrie
XTXuejuan Tan
Xuejuan Tan
AMAmber Cherry Meeker
Amber Cherry Meeker
ASAshton Elisabeth Self
Ashton Elisabeth Self
LLLin Liu
Lin Liu
YCYong Cheng
Yong Cheng
The COVID-19 pandemic, caused by SARS-CoV-2 virus, has been one of the top public health threats across the world over the past three years. Mycobacterium bovis BCG is currently the only licensed vaccine for tuberculosis, one of the deadliest infectious diseases in the world, that is caused by Mycobacterium tuberculosis. In the past decades, recombinant M.bovis BCG has been studied as a novel vaccine vector for other infectious diseases in humans besides tuberculosis, such as viral infections. In the current study, we generated a recombinant M. bovis BCG strain AspikeRBD that expresses a fusion protein consisting of M. tb Ag85A protein and the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein using synthetic biology technique. Our results show that the recombinant M. bovis BCG strain successfully expressed this fusion protein. Interestingly, the recombinant M. bovis BCG strain AspikeRBD significantly induced SARS-CoV-2 spike-specific T cell activation and IgG production in mice when compared to the parental M.bovis BCG strain, and was more potent than the recombinant M.bovis BCG strain expressing SARS-CoV-2 spike RBD alone. As expected, the recombinant M. bovis BCG strain AspikeRBD activated an increased number of M. tb Ag85A-specific IFNγ-releasing T cells and enhanced IgG production in mice when compared to the parental M.bovis BCG strain or the BCG strain expressing SARS-CoV-2 spike RBD alone. Taken together, our results indicate a potential application of the recombinant M. bovis BCG strain AspikeRBD as a novel dual vaccine against SARS-CoV-2 and M. tb in humans.